FCMI
Foresite Capital Management I Portfolio holdings
AUM
$21.4M
This Quarter Return
+42.73%
1 Year Return
-80.48%
3 Year Return
-40.72%
5 Year Return
–
10 Year Return
–
AUM
$317M
AUM Growth
+$317M
(-12%)
Cap. Flow
-$200M
Cap. Flow
% of AUM
-63.18%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
EPZM
Epizyme, Inc
EPZM
|
$3.92M |
Top Sells
| 1 |
10x Genomics
TXG
|
$204M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
10x Genomics
TXG
$1.74B
| $313M | 98.53% | 3,500,000 -2,288,317 | -40% | -$204M |
|
|
EPZM
2
DELISTED
Epizyme, Inc
EPZM
| $3.92M | 1.23% | +243,759 | New | +$3.92M |
|
|
XLRN
3
DELISTED
Acceleron Pharma Inc.
XLRN
| $762K | 0.24% | 8,000 | – | – |
|